Nephrotoxic drugs: Difference between revisions
m Protected "Nephrotoxic drugs": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | ||
'''Associate Editor-In-Chief:''' {{CZ}} | |||
==Overview== | |||
Nephrotoxic drugs are pharmacotherapies that can lead to a decline in renal function. The drug may need to be discontinued, or the dosing reduced when this happens. | |||
==Antibiotics== | ==Antibiotics== |
Revision as of 12:16, 9 August 2012
WikiDoc Resources for Nephrotoxic drugs |
Articles |
---|
Most recent articles on Nephrotoxic drugs Most cited articles on Nephrotoxic drugs |
Media |
Powerpoint slides on Nephrotoxic drugs |
Evidence Based Medicine |
Cochrane Collaboration on Nephrotoxic drugs |
Clinical Trials |
Ongoing Trials on Nephrotoxic drugs at Clinical Trials.gov Trial results on Nephrotoxic drugs Clinical Trials on Nephrotoxic drugs at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Nephrotoxic drugs NICE Guidance on Nephrotoxic drugs
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Nephrotoxic drugs Discussion groups on Nephrotoxic drugs Patient Handouts on Nephrotoxic drugs Directions to Hospitals Treating Nephrotoxic drugs Risk calculators and risk factors for Nephrotoxic drugs
|
Healthcare Provider Resources |
Causes & Risk Factors for Nephrotoxic drugs |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Nephrotoxic drugs are pharmacotherapies that can lead to a decline in renal function. The drug may need to be discontinued, or the dosing reduced when this happens.
Antibiotics
- Aminoglycosides (10-15% Incidence of Acute Tubular Necrosis)
- Occurs in 10-20% patients on 7 day course
- Results in non-oligurics; increased Creatinine
- A single dose early in septic course is usually safe
- Sulfonamides
- Amphotericin B (Incidence 80-90%)
- Levofloxacin
- Ciprofloxacin
- Rifampin
- Tetracycline
- Acyclovir (only nephrotoxic in intravenous form)
- Pentamidine
Chemotherapy and Immunosuppressants
Heavy Metals
- Polydipsia and Nephrogenic Diabetes Insipidus
- Acute Renal Failure
- Dialysis indications: Creatinine >2.5 or Seizures, ALOC, Rhabdomyolysis
- Chronic kidney disease with fibrosis
AntiHyperlipidemics
- Associated with Acute Renal Failure due to Rhabdomyolysis
- Fenofibrate (Tricor)
- Increases Serum Creatinine without significant decrease in GFR
- Serum Creatinine rise is reversible on stopping Fenofibrate
Chemotherapy
- Cisplatin
- Ifosphamide
- Causes Fanconi's Syndrome
Miscellaneous Drugs
- Chronic Stimulant Laxative use
- Resulting chronic volume depletion and Hypokalemia causes nephropathy
- Radiographic contrast
- ACE Inhibitors
- Expect an increase of Serum Creatinine in Chronic kidney disease
- Low dose Aspirin reduces Renal function in elderly
- Decreased Creatinine Clearance after 2 weeks of use
- Changes persisted for at least 3 weeks off Aspirin
- Low dose Aspirin reduces Renal function in elderly
- Mesalamine (Asacol, Pentasa)
- Mesalamine is an NSAID analog and has systemic absorption from the bowel
- Vasculitis reaction
- Nephrotic Syndrome type reaction